nasdaqsava
SAVA stock looks poised to regain YTD decline as investors see potential of biopharma’s Alzheimer’s disease treatment Shares of Austin, Texas-based neuroscience biopharma company Cassava Sciences Inc (NASDAQ:SAVA) surged 11.73% in extended trading after a Form 4 filing disclosed an independent board director made a significant purchase in the post-fourth quarter results trading window. Q4 2022 hedge fund letters, conferences and more Find A Qualified Financial AdvisorEach advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you're ready to...
ValueWalk
Whitney Tilson’s email to investors discussing Hard Money’s Million Dollar Podcast up more than 10x; why he no longer short stocks; Cassava Sciences Inc (NASDAQ:SAVA); Nikola Corporation (NASDAQ:NKLA); Zillow Group Inc (NASDAQ:ZG). Q3 2021 hedge fund letters, conferences and more Hard Money's Million Dollar Podcast Up More Than 10x1) I want to give a shout-out to my colleagues Enrique Abeyta and Gabe Marshank, who are crushing it with their Hard Money's Million Dollar Podcast, which follows them as they try to turn $10,000 into $1 million – or go bust trying. It's a total balls-to-the-wall app...
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら